Cancer Immunology Immunotherapy
Springer Science+Business Media · Q1
ISSN: 0340-7004 · 1432-0851
Rankings & quartile
| System | Value | Year | Source |
|---|---|---|---|
| SCImago (SJR) | 1.805 Q1 | 2025 | source |
| Citation impact (OpenAlex) | 31.5 cites/work Q2 | 2026 | source |
| h-index | 163 | 2026 | source |
Last updated 2026-05-19 · OpenAlex profile
Cite this profile
APA 7Journal Check. (2026). Cancer Immunology Immunotherapy: Journal rankings & quartile. Journal Check. https://journal-check.com/journals/S203303425/cancer-immunology-immunotherapy MLA 9"Cancer Immunology Immunotherapy: Journal rankings & quartile." Journal Check, 2026, https://journal-check.com/journals/S203303425/cancer-immunology-immunotherapy. Chicago 17Journal Check. "Cancer Immunology Immunotherapy: Journal rankings & quartile." 2026. https://journal-check.com/journals/S203303425/cancer-immunology-immunotherapy. GB/T 7714Journal Check. Cancer Immunology Immunotherapy: Journal rankings & quartile[EB/OL]. (2026). https://journal-check.com/journals/S203303425/cancer-immunology-immunotherapy.See rankings while you search
Journal Check shows this journal's quartile right next to its papers on Google Scholar, PubMed, arXiv and Semantic Scholar.
Add to Chrome — free